These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1851794)

  • 21. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
    Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
    Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of solid-phase C1Q to remove soluble antigen/antibody complexes in an inhibition ELISA for streptococcal cell membrane antigens.
    Zelman ME; Lange CF
    J Immunoassay; 1990; 11(4):545-54. PubMed ID: 2283393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological functions of C1q expressed by conformational changes.
    Heinz HP
    Behring Inst Mitt; 1989 Jul; (84):20-31. PubMed ID: 2478117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody formation against human collagen and C1q in response to a bovine collagen implant.
    Trautinger F; Kokoschka EM; Menzel EJ
    Arch Dermatol Res; 1991; 283(6):395-9. PubMed ID: 1796822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1q, antibodies and anti-C1q autoantibodies.
    Beurskens FJ; van Schaarenburg RA; Trouw LA
    Mol Immunol; 2015 Nov; 68(1):6-13. PubMed ID: 26032012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of anti-C1q antibodies in IgA nephropathy.
    Gunnarsson I; Rönnelid J; Lundberg I; Jacobson SH
    Nephrol Dial Transplant; 1997 Nov; 12(11):2263-8. PubMed ID: 9394309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A C1Q enzyme-linked immunosorbent assay (ELISA) using polyethylene glycol for immune complexes.
    Lunde MN
    Am J Trop Med Hyg; 1983 Mar; 32(2):392-6. PubMed ID: 6340543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice.
    Hogarth MB; Norsworthy PJ; Allen PJ; Trinder PK; Loos M; Morley BJ; Walport MJ; Davies KA
    Clin Exp Immunol; 1996 May; 104(2):241-6. PubMed ID: 8625515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.